Update on COVID-19 Vaccine Availability in States/UTs

0
261
Vial of the Oxford–AstraZeneca vaccine manufactured by the Serum Institute of India (marketed as Covishield in India and in a few other countries)
Vial of the Oxford–AstraZeneca vaccine manufactured by the Serum Institute of India (marketed as Covishield in India and in a few other countries)
ShyamSundarCoJwellers

Update on COVID-19 Vaccine Availability in States/UTs

More than 72.21Crore vaccine doses provided to States/UTs

More than 5.16 Crore balance and unutilized vaccine doses still available with States/UTs with more than 57 Lakh doses in Pipeline

By PIB Delhi

The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.

As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.

 VACCINE DOSES (As on 12thSeptember 2021)
 SUPPLIED 72,21,17,085
 PIPELINE 57,56,240
 BALANCE AVAILABLE  5,16,66,835

More than 72.21 crore (72,21,17,085) vaccine doses have been provided to States/UTs so far through Govt of India (free of cost channel) and through direct state procurement category.Further, more than 57 Lakh doses (57,56,240) are in the pipeline.

More than 5.16Cr (5,16,66,835) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.

Advertisements IBGNewsCovidService
USD